293 related articles for article (PubMed ID: 8901962)
1. Low-dose inhalation therapy with nitric oxide and oxygen--implications for long-term application in patients with COPD and pulmonary hypertension.
Leitner C; Ziesche R; Zimpfer M; Block LH; Germann P
Acta Anaesthesiol Scand Suppl; 1996; 109():96-7. PubMed ID: 8901962
[No Abstract] [Full Text] [Related]
2. Present role of nitric oxide inhalation in severe lung failure.
Rossaint R; Kelly K; Kaisers U
Acta Anaesthesiol Scand Suppl; 1996; 109():88-92. PubMed ID: 8901960
[No Abstract] [Full Text] [Related]
3. Addition of nitric oxide to oxygen improves cardiopulmonary function in patients with severe COPD.
Germann P; Ziesche R; Leitner C; Roeder G; Urak G; Zimpfer M; Sladen R
Chest; 1998 Jul; 114(1):29-35. PubMed ID: 9674443
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide inhalation in acute pulmonary hypertension after cardiac surgery reduces oxygen concentration and improves mechanical ventilation but not mortality.
Westphal K; Martens S; Strouhal U; Matheis G; Hommel K; Kessler P
Thorac Cardiovasc Surg; 1998 Apr; 46(2):70-3. PubMed ID: 9618806
[TBL] [Abstract][Full Text] [Related]
5. Inhaled nitric oxide.
Zapol WM
Acta Anaesthesiol Scand Suppl; 1996; 109():81-3. PubMed ID: 8901957
[TBL] [Abstract][Full Text] [Related]
6. [Low dose inhalation of nitric oxide in chronic obstructive pulmonary diseases].
Yoshida M; Taguchi O; Gabazza EC; Yasui H; Kobayashi T; Yamakami T; Kobayashi H
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jan; 35(1):56-60. PubMed ID: 9071157
[TBL] [Abstract][Full Text] [Related]
7. Effects of inhaled nitric oxide in patients with hypoxemia and pulmonary hypertension after cardiac surgery.
Bender KA; Alexander JA; Enos JM; Skimming JW
Am J Crit Care; 1997 Mar; 6(2):127-31. PubMed ID: 9172849
[TBL] [Abstract][Full Text] [Related]
8. Indications, modifications and technique of ECMO with or without NO-therapy.
Pappert D; Falke KJ
Acta Anaesthesiol Scand Suppl; 1996; 109():117-20. PubMed ID: 8901974
[No Abstract] [Full Text] [Related]
9. Inhaled nitric oxide does not improve cardiac or pulmonary function in patients with an exacerbation of chronic obstructive pulmonary disease.
Baigorri F; Joseph D; Artigas A; Blanch L
Crit Care Med; 1999 Oct; 27(10):2153-8. PubMed ID: 10548198
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
[TBL] [Abstract][Full Text] [Related]
11. A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
Khan TA; Schnickel G; Ross D; Bastani S; Laks H; Esmailian F; Marelli D; Beygui R; Shemin R; Watson L; Vartapetian I; Ardehali A
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1417-24. PubMed ID: 19931670
[TBL] [Abstract][Full Text] [Related]
12. [Obstructive pulmonary hypertension: effect of aminophylline, hyperventilation and O 2 respiration].
Renggli I; Daum S
Schweiz Med Wochenschr; 1971 Mar; 101(10):352-7. PubMed ID: 5558550
[No Abstract] [Full Text] [Related]
13. Effects of inhaled prostacyclin as compared with inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction.
Zwissler B; Welte M; Messmer K
J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):283-9. PubMed ID: 7669961
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary hypertension: the role of nitric oxide in adults].
Neidecker J
Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):457-9. PubMed ID: 11792299
[TBL] [Abstract][Full Text] [Related]
15. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
[TBL] [Abstract][Full Text] [Related]
16. Effects of prostaglandin E1 (PGE1) in pulmonary hypertension due to chronic obstructive pulmonary disease (COPD).
Meissner E; Creutzig A; Fabel H
Prog Clin Biol Res; 1989; 301():253-7. PubMed ID: 2798450
[No Abstract] [Full Text] [Related]
17. [Acute and long-term effects of chronic obstructive lung diseases].
Klein G; Matthys H
Pneumologie; 1990 Feb; 44 Suppl 1():188-90. PubMed ID: 2114622
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
[TBL] [Abstract][Full Text] [Related]
19. Inhaled nitric oxide reduction in systolic pulmonary artery pressure is less in patients with decreased left ventricular ejection fraction.
Cujec B; Hurst T; McCuaig R; Antecol D; Mayers I; Johnson D
Can J Cardiol; 1997 Sep; 13(9):816-24. PubMed ID: 9343030
[TBL] [Abstract][Full Text] [Related]
20. Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension.
Findlay JY; Harrison BA; Plevak DJ; Krowka MJ
Liver Transpl Surg; 1999 Sep; 5(5):381-7. PubMed ID: 10477839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
